Tilray Brands, Inc. (TLRY) — SEC Financial Statements & Analysis

Tilray Brands, Inc. (TLRY) is a medicinal chemicals & botanical products company. Tilray Brands, Inc. trades on Nasdaq as: TLRY. Tilray Brands, Inc. (TLRY)'s most recent SEC filing is a Form 10-K for the period ended 2026-05-31, filed with the SEC on 2026-07-28. Based on its latest SEC filing (Form 10-Q, period ending 2026-05-31), Tilray Brands, Inc. carries a market cap of $616.20M, a P/E ratio of -5.86x, a P/B ratio of 0.39x, a P/S ratio of 0.67x, an enterprise value of $617.11M, and an EV/EBITDA multiple of -9.79x. On profitability, it posts a gross margin of 28.45%, an operating margin of -6.88%, a net margin of -11.49%, a Return on Equity (ROE) of -6.82%, a Return on Assets (ROA) of -4.78%, and a Return on Invested Capital (ROIC) of -4.00%. Per share, it reports EPS of $-0.94, diluted EPS of $-0.94, free cash flow per share of $-1.10, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 11.46% year-over-year, net income growth of -95.19% year-over-year, and EPS growth of -96.17% year-over-year. On the balance sheet, it maintains a current ratio of 2.21x, a quick ratio of 1.19x, working capital of $433.75M, a debt-to-equity ratio of 0.46x, a debt ratio of 0.31, an interest coverage ratio of -2.66x, free cash flow of $-122.84M (TTM), and net debt of $912.00K. Figures sourced from SEC EDGAR.

Market Cap

$616.20M

P/E TTM

-5.86x

EPS TTM

$-0.94

P/B TTM

0.39x

ROE TTM

-6.82%

ROA TTM

-4.78%

Debt To Equity

0.46x

Free Cash Flow TTM

$-122.84M

Net Revenue TTM Growth 1Y

11.46%

Data as of 2026-05-31 · Source: SEC EDGAR